The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans*
Abstract
Achondroplasia, the most common form of short-limbed dwarfism in humans, occurs between 1 in 15,000 and 40,000 live births. More than 90% of cases are sporadic and there is, on average, an increased paternal age at the time of conception of affected individuals. More then 97% of persons with achondroplasia have a Gly380Arg mutation in the transmembrane domain of the fibroblast growth factor receptor (FGFR) 3 gene. Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans. Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active. Since the Gly380Arg achondroplasia mutation was recognized, similar observations regarding the conserved nature of FGFR mutations and resulting phenotype have been made regarding other skeletal phenotypes, including hypochondroplasia, thanatophoric dysplasia, and Muenke coronal craniosynostosis. These specific genotype-phenotype correlations in the FGFR disorders seem to be unprecedented in the study of human disease. The explanation for this high degree of mutability at specific bases remains an intriguing question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Smith's recognizable patterns of human malformation
Jones, K. L., Jones, M. C., & Campo, M. D. (1997) · Cited by 1,916
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329
Structural and Functional Diversity in the FGf Receptor Multigene Family
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60821-0 · Cited by 1,250
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Biological Roles of Fibroblast Growth Factor-2*
Bikfalvi, A., Klein, S., Pintucci, G., & Rifkin, D. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0292 · Cited by 959
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.-M., Maroteaux, P., Merrer, M. L., & Munnich, A. (1994) · Nature · doi:10.1038/371252a0 · Cited by 928
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0496-390 · Cited by 873
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 758
The roles of FGFs in the early development of vertebrate limbs
Martin, G. R. (1998) · Genes & Development · doi:10.1101/gad.12.11.1571 · Cited by 648
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614 · cited 1×
“dromes (19, 20, 68); interestingly, all three phenotypes can be caused by a FGFR2 Cys342Arg mutation.”
Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y.-Z., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., & Wasmuth, J. J. (1995) · Nature Genetics · doi:10.1038/ng0395-321 · Cited by 601
Self-citationThe ins and outs of fibroblast growth factors
Mason, I. J. (1994) · Cell · doi:10.1016/0092-8674(94)90520-7 · Cited by 524
Naski, M. C., Wang, Q., Xu, J., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0696-233 · Cited by 498
Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus, G. A., Hefferon, T. W., Luna, R. I. O. D., Hecht, J. T., Horton, W. A., Machado, M. A., Kaitila, I., McIntosh, I., & Francomano, C. A. (1995) · PubMed Central · Cited by 473
Self-citationBellus, G. A., McIntosh, I., Smith, E. A., Aylsworth, A. S., Kaitila, I., Horton, W. A., Greenhaw, G. A., Hecht, J. T., & Francomano, C. A. (1995) · Nature Genetics · doi:10.1038/ng0795-357 · Cited by 473
Self-citationJabs, E. W., Li, X., Scott, A. F., Meyers, G., Chen, W., Eccles, M., Mao, J.-I., Charnas, L. R., Jackson, C. E., & Jaye, M. (1994) · Nature Genetics · doi:10.1038/ng1194-275 · Cited by 468
Schlessinger, J., Lax, I., & Lemmon, M. (1995) · Cell · doi:10.1016/0092-8674(95)90112-4 · Cited by 465
Unique Expression Pattern of the FGF Receptor 3 Gene during Mouse Organogenesis
Peters, K., Ornitz, D., Werner, S., & Williams, L. (1993) · Developmental Biology · doi:10.1006/dbio.1993.1040 · Cited by 455
Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-173 · Cited by 451
Muenke, M., Gripp, K. W., McDonald‐McGinn, D. M., Gaudenz, K., Whitáker, L. A., Bartlett, S. P., Markowitz, R. I., Robin, N. H., Nwokoro, N., Mulvihill, J. J., et al. (1997) · PubMed · Cited by 449
Self-citationComplexity of FGF receptors: genetic basis for structural diversity and functional specificity
Givol, D., & Yayon, A. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1464370 · Cited by 435
Naski, M. C., Colvin, J. S., Coffin, J. D., & Ornitz, D. M. (1998) · Development · doi:10.1242/dev.125.24.4977 · Cited by 420
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.
Keegan, K., Johnson, D. E., Williams, L. T., & Hayman, M. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1095 · Cited by 411
Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W. (1995) · Nature Genetics · doi:10.1038/ng1295-462 · Cited by 390
Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M., & Schlessinger, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.977 · Cited by 388
Structure of the FGF Receptor Tyrosine Kinase Domain Reveals a Novel Autoinhibitory Mechanism
Mohammadi, M., Schlessinger, J., & Hubbard, S. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80131-2 · Cited by 370
Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A., & Muenke, M. (1996) · Nature Genetics · doi:10.1038/ng1096-174 · Cited by 316
Self-citationWebster, M. K., & Donoghue, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00384.x · Cited by 307
Su, W.-C. S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., & Fu, X.-Y. (1997) · Nature · doi:10.1038/386288a0 · Cited by 304
Chellaiah, A. T., McEwen, D. G., Werner, S., Xu, J., & Ornitz, D. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78170-8 · Cited by 296
The type II collagenopathies: A spectrum of chondrodysplasias
Spranger, J., Winterpacht, A., & Zabel, B. (1994) · European Journal of Pediatrics · doi:10.1007/bf01959208 · Cited by 261
Birth prevalence rates of skeletal dysplasias
Stoll, C., Dott, B., Roth, M., & Alembik, Y. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb02912.x · Cited by 234
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome
Schell, U., Hehr, A., Feldman, G. J., Robin, N. H., Zackai, E. H., de Die-Smulders, C., Viskochil, D. H., Stewart, J. M., Wolff, G., Ohashi, H., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.3.323 · Cited by 234
Johnson, D., Horsley, S. W., Moloney, D. M., Oldridge, M., Twigg, S. R. F., Walsh, S., Barrow, M., Njølstad, P. R., Kunz, J., Ashworth, G. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302122 · Cited by 230
Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.
(1996) · PubMed Central · Cited by 229
Wilkin, D. J., Szabo, J. K., Cameron, R., Henderson, S., Bellus, G. A., Mack, M. L., Kaitila, I., Loughlin, J., Munnich, A., Sykes, B., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302000 · Cited by 228
Self-citationA mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3
Wang, Y., Spatz, M. K., Kannan, K., Hayk, H., Avivi, A., Gorivodsky, M., Pines, M., Yayon, A., Lonai, P., & Givol, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4455 · Cited by 228
Li, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.35 · Cited by 219
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
Rousseau, F., Saugier, P., Merrer, M. L., Munnich, A., Delezoide, A.-L., Maroteaux, P., Bonaventure, J., Narcy, F., & Sanak, M. (1995) · Nature Genetics · doi:10.1038/ng0595-11 · Cited by 201
Fibroblast growth factor receptor 2 mutations in Beare–Stevenson cutis gyrata syndrome
Przylepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-492 · Cited by 185
FGFR2 mutations in Pfeiffer syndrome
Lajeunie, E., Ma, H. W., Bonaventure, J., Munnich, A., Le Merrer, M., & Renier, D. (1995) · Nature Genetics · doi:10.1038/ng0295-108 · Cited by 180
Oberklaid, F., Danks, D. M., Jensen, F., Stace, L., & Rosshandler, S. (1979) · Journal of Medical Genetics · doi:10.1136/jmg.16.2.140 · Cited by 180
Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification
Delezoide, A.-L., Benoist-Lasselin, C., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Vekemans, M., & Bonaventure, J. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00133-6 · Cited by 177
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
Rousseau, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.509 · Cited by 173
Webster, M. K., d’Avis, P. Y., Robertson, S. C., & Donoghue, D. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4081 · Cited by 172
Park, W.-J., Meyers, G. A., Li, X., Theda, C., Day, D., Oriow, S. J., Jones, M. C., & Jabs, E. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.7.1229 · Cited by 172
Meyers, G. A., Day, D., Goldberg, R. B., Daentl, D. L., Przylepa, K. A., Abrams, L., Graham, J., Feingold, M., Moeschler, J. B., Rawnsley, E. F., et al. (1996) · PubMed Central · Cited by 168
Tavormina, P. L., Bellus, G. A., Webster, M. K., Bamshad, M. J., Fraley, A. E., McIntosh, I., Szabo, J., Jiang, W., Jabs, E. W., Wilcox, W. R., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302275 · Cited by 161
Self-citationNeilson, K. M., & Friesel, R. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.25049 · Cited by 158
Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia
Wilcox, W. R., Tavormina, P. L., Krakow, D., Kitoh, H., Lachman, R. S., Wasmuth, J. J., Thompson, L. M., & Rimoin, D. L. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980707)78:3<274::aid-ajmg14>3.0.co;2-c · Cited by 157
Neilson, K. M., & Friesel, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26037 · Cited by 149
Hu, M. C. ‐., Qiu, W. R., Wang, Y., Hill, D., Ring, B. D., Scully, S. A., Bolon, B. N., DeRose, M., Luethy, R., Simonet, W. S., et al. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.6063 · Cited by 147
Galvin, B. D., Hart, K. C., Meyer, A. N., Webster, M. K., & Donoghue, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7894 · Cited by 143
Legeai‐Mallet, L., Benoist-Lasselin, C., Delezoide, A., Münnich, A., & Bonaventure, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13007 · Cited by 141
Signal Transduction Pathway of Human Fibroblast Growth Factor Receptor 3
Kanai, M., Göke, M. N., Tsunekawa, S., & Podolsky, D. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6621 · Cited by 139
Belluardo, N., Wu, G., Mudò, G., Hansson, A., Pettersson, R. F., & Fuxé, K. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970310)379:2<226::aid-cne5>3.0.co;2-5 · Cited by 139
Promiscuity of fibroblast growth factor receptors
Green, P. J., Walsh, F. S., & Doherty, P. (1996) · BioEssays · doi:10.1002/bies.950180807 · Cited by 137
Bonaventure, J., Rousseau, F., Legeai‐Mallet, L., Merrer, M. F. L., Münnich, A., & MAROTEAUX, P. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960503)63:1<148::aid-ajmg26>3.0.co;2-n · Cited by 137
Clinical and genetic heterogeneity of hypochondroplasia.
Rousseau, F., Bonaventure, J., Legeai‐Mallet, L., et al. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.9.749 · Cited by 137
A common FGFR3 gene mutation in hypochondroplasia
Prinos, P., Costa, T., Sommer, A., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2097 · Cited by 134
Bellus, G. A., Bamshad, M. J., Przylepa, K. A., Dorst, J. P., Lee, R. R., Hurko, O., Jabs, E. W., Curry, C. J., Wilcox, W. R., Lachman, R. S., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990702)85:1<53::aid-ajmg10>3.0.co;2-f · Cited by 130
Self-citationAchondroplasia and hypochondroplasia. Clinical variation and spinal stenosis
Wynne-Davies, R., Walsh, W., & Gormley, J. (1981) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.63b4.7298674 · Cited by 125
Long-term survival in typical thanatophoric dysplasia type 1
Baker, K. M., Olson, D. S., Harding, C. O., & Pauli, R. M. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970627)70:4<427::aid-ajmg18>3.0.co;2-j · Cited by 118
Thompson, L. M., Plummer, S. J., Schalling, M., Altherr, M. R., Gusella, J. F., Housman, D. E., & Wasmuth, J. J. (1991) · Genomics · doi:10.1016/0888-7543(91)90041-c · Cited by 115
Superti‐Furga, A., Steinmann, B. U., GITZELMANN, R., Eich, G. F., Giedion, A., Bucher, H., & Wisser, J. (1995) · European Journal of Pediatrics · doi:10.1007/bf01954274 · Cited by 112
Hypochondroplasia: Clinical and Radiological Aspects in 39 cases
Hall, B. D., & Spranger, J. (1979) · Radiology · doi:10.1148/133.1.95 · Cited by 108
Hecht, D., Zimmerman, N., Bedford, M. T., Avivi, A., & Yayon, A. (1995) · Growth Factors · doi:10.3109/08977199509036882 · Cited by 108
Sorokin, A., Lemmon, M. A., Ullrich, A., & Schlessinger, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36947-8 · Cited by 103
Expression and Biological Activity of Mouse Fibroblast Growth Factor-9 (*)
Santos-Ocampo, S., Colvin, J. S., Chellaiah, A., & Ornitz, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1726 · Cited by 103
Reardon, W., Wilkes, D. C., Rutland, P., Pulleyn, L. J., Malcolm, S., Dean, J., Evans, R. D., Jones, B. M., Hayward, R. D., Hall, C. M., et al. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.8.632 · Cited by 100
Tavormina, P. L., Rimoin, D. L., Cohn, D. H., Zhu, Y., Shiang, R., & Wasmuth, J. J. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2175 · Cited by 98
A novel form of FGF receptor‐3 using an alternative exon in the immunoglobulin domain III
Avivi, A., Yayon, A., & Givol, D. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80882-u · Cited by 97
Wilkes, D. C., Rutland, P., Pulleyn, L. J., Reardon, W., Moss, C., Ellis, J. P., Winter, R. M., & Malcolm, S. (1996) · Journal of Medical Genetics · doi:10.1136/jmg.33.9.744 · Cited by 92
Gorry, M. C., Preston, R. A., White, G. J., Zhang, Y., Singhal, V. K., Losken, H. W., Parker, M. G., Nwokoro, N. A., Post, J. C., & Ehrlich, G. D. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1387 · Cited by 90
Green, P. M., Montandon, A. J., Bentley, D., Ljung, R. C. R., Nilsson, I. M., & Giannelli, F. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.11.3227 · Cited by 81
Spranger, J. W. (2008) · Pathology and Immunopathology Research · doi:10.1159/000157098 · Cited by 80
Phenotype of the fibroblast growth factor receptor 2 Ser351Cys mutation: Pfeiffer syndrome type III
Gripp, K. W., Stolle, C. A., McDonald‐McGinn, D. M., Markowitz, R. I., Bartlett, S. P. P., Katowitz, J. A., Muenke, M., & Zackai, E. H. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980724)78:4<356::aid-ajmg10>3.0.co;2-h · Cited by 78
Francomano, C. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320113 · Cited by 67
Self-citationIkegawa, S., Fukushima, Y., Isomura, M., Takada, F., & Nakamura, Y. (1995) · Human Genetics · doi:10.1007/bf00210413 · Cited by 65
Steinberger, D., Reinhartz, T., Unsöld, R., & Müller, U. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19961202)66:1<81::aid-ajmg19>3.0.co;2-m · Cited by 59
Tanaka, H., Kubo, T., Yamate, T., et al. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380275 · Cited by 59
Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations
Brodie, S. G., Kitoh, H., Lachman, R. S., Nolasco, L. M., Mekikian, P. B., & Wilcox, W. R. (1999) · American Journal of Medical Genetics · Cited by 58
Tartaglia, M., Rocco, C. D., Lajeunie, E., Valeri, S., Velardi, F., & Battaglia, P. A. (1997) · Human Genetics · doi:10.1007/s004390050584 · Cited by 57
Tartaglia, M., Valeri, S., Velardi, F., Rocco, C. D., & Battaglia, P. A. (1997) · Human Genetics · doi:10.1007/s004390050413 · Cited by 52
McEwen, D. G., & Ornitz, D. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5349 · Cited by 51
Steinberger, D., Mulliken, J. B., & M�ller, U. (1995) · Human Genetics · doi:10.1007/bf00214198 · Cited by 49
Wüchner, C., NORDQVIST, A. C. S., Winterpacht, A., Zabel, B., & Schalling, M. (1996) · The International Journal of Developmental Biology · doi:10.1387/ijdb.9032024 · Cited by 49
Raffioni, S., Zhu, Y., Bradshaw, R. A., & Thompson, L. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35250 · Cited by 48
Golla, A., Lichmer, P., von Gernet, S., Winterpacht, A., Fairley, J. D., Murken, J. D., & Schuffenhauer, S. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.8.683 · Cited by 44
Jugular Foraminal Stenosis in Crouzon Syndrome
Martı́nez-Pérez, D., Woude, D. L. V., Barnes, P. D., Scott, M., & Mulliken, J. B. (2008) · Pediatric Neurosurgery · doi:10.1159/000121134 · Cited by 37
Steinberger, D., Mulliken, J. B., & Müller, U. (1996) · Human Mutation · Cited by 35
Roussel, M. F., Downing, J. R., & Sherr, C. J. (1990) · PubMed · Cited by 31
Mental retardation, ?coarse? face, and hyperbreathing: Confirmation of the Pitt-Hopkins syndrome
Balkom, I. D. C. V., Quartel, S., & Hennekam, R. C. M. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980123)75:3<252::aid-ajmg4>3.0.co;2-s · Cited by 26
Brown, D. C., Stirling, H. F., Butler, G. E., Kelnar, C. J. H., & Wu, F. C. W. (2008) · Hormone Research · doi:10.1159/000185001 · Cited by 23
Thompson, L. M., Raffioni, S., Wasmuth, J. J., & Bradshaw, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4169 · Cited by 23
Steinberger, D., Collmann, H., Schmalenberger, B., & Müller, U. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.5.420 · Cited by 19
Kitoh, H., Brodie, S. G., Kupke, K. G., et al. (1998) · PubMed · Cited by 14
Cited by
The origins, patterns and implications of human spontaneous mutation
Crow, J. F. (2000) · Nature Reviews Genetics · doi:10.1038/35049558 · Cited by 928
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Systemic and Local Regulation of the Growth Plate
van der Eerden, B. C. J., Karperien, M., & Wit, J. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0033 · Cited by 558
Fibroblast growth factor signaling in skeletal development and disease
Ornitz, D. M., & Marie, P. J. (2015) · Genes & Development · doi:10.1101/gad.266551.115 · Cited by 418
Molecular mechanisms of endochondral bone development
Provot, S., & Schipani, E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.068 · Cited by 375
Metadata
- Authors
- Vajo, Z., Francomano, C. A., & Wilkin, D. J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2000-02-01
- Volume
- 21
- Issue
- 1
- Pages
- 23-39
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2139260705
- Cited by
- 350
- References
- 103
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.